These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8084529)

  • 21. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
    Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
    Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
    Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
    Keegan KD; Woodruff GN; Pinnock RD
    Br J Pharmacol; 1992 Jan; 105(1):3-5. PubMed ID: 1375857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.
    Xue Y; Bai B; Yung WH; Chen L
    Neurosignals; 2009; 17(2):153-61. PubMed ID: 19202346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin excitation of serotonergic neurons in the dorsal raphe nucleus of the rat in vitro.
    Jolas T; Aghajanian GK
    Eur J Neurosci; 1996 Jan; 8(1):153-61. PubMed ID: 8713459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro.
    Coogan AN; Rawlings N; Luckman SM; Piggins HD
    Neuroscience; 2001; 103(3):663-72. PubMed ID: 11274786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
    Chen L; Yung KK; Yung WH
    Neuroscience; 2004; 125(4):853-9. PubMed ID: 15120846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.
    Li AH; Yeh TH; Tan PP; Hwang HM; Wang HL
    Neuropharmacology; 2001 Jun; 40(8):1073-83. PubMed ID: 11406199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons.
    Mercuri NB; Stratta F; Calabresi P; Bernardi G
    Neurosci Lett; 1993 Apr; 153(2):192-6. PubMed ID: 7687049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurotensin analog xenopsin excites nigral dopamine neurons.
    Pozza MF; Küng E; Bischoff S; Olpe HR
    Eur J Pharmacol; 1988 Jan; 145(3):341-3. PubMed ID: 3350051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotensin modulates synaptic transmission in the nucleus of the solitary tract of the rat.
    Ogawa WN; Baptista V; Aguiar JF; Varanda WA
    Neuroscience; 2005; 130(2):309-15. PubMed ID: 15664687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.
    Brouard A; Heaulme M; Leyris R; Pelaprat D; Gully D; Kitabgi P; Le Fur G; Rostene W
    Eur J Pharmacol; 1994 Mar; 253(3):289-91. PubMed ID: 8200423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SR 48692, a non-peptide neurotensin receptor antagonist, blocks the cardiovascular effects elicited by neurotensin in guinea pigs.
    Nisato D; Guiraudou P; Barthélémy G; Gully D; Le Fur G
    Life Sci; 1994; 54(7):PL95-100. PubMed ID: 8309346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
    Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurotensin receptor antagonists and therapeutical perspectives].
    Gully D; Maffrand JP; Soubrié P; Rostène W; Kitabgi P; Le Fur G
    Therapie; 1995; 50(1):5-7. PubMed ID: 7754478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
    Reynolds SM; Geisler S; Bérod A; Zahm DS
    Eur J Neurosci; 2006 Jul; 24(1):188-96. PubMed ID: 16882016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.
    Rowe WB; Nicot A; Sharma S; Gully D; Walker CD; Rostène WH; Meaney MJ; Quirion R
    Neuroendocrinology; 1997 Aug; 66(2):75-85. PubMed ID: 9263204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro.
    Meyer-Spasche A; Reed HE; Piggins HD
    Eur J Neurosci; 2002 Jul; 16(2):339-44. PubMed ID: 12169114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.